Results
Ten trials were included in the final analysis (N¼2,280). There was improvement in the recovery of facial function when combination therapy (antivirals plus corticosteroids) was used compared with corticosteroids alone or no treatment. Moreover, there was a reduction in long-term sequelae of Bell's palsy, such as motor synkinesis and crocodile tears, when patients were treated with the combination of antivirals and corticosteroids. There was no difference in adverse events between any of the treatment groups (Table) .
Of the 10 trials, only 3 were of lower risk of bias. The quality of evidence was either low or low to moderate for both the primary and secondary outcomes.
Commentary
Bell's palsy is an idiopathic, acute, unilateral paralysis or weakness of facial musculature stemming from peripheral facial nerve (cranial nerve VII) dysfunction. Up to 30% of patients with Bell's palsy never fully recover facial function. Recent studies have suggested an annual incidence of Bell's palsy up to 37 per 100,000 people per year. 1, 2 Corticosteroids are widely used in the treatment of Bell's palsy. 3, 4 However, the effectiveness of combining an antiviral with a corticosteroid continues to be debated. This Cochrane review was first published in 2001 and revised in 2009. In the latter version, only 2 randomized controlled trials were included and suggested that antivirals did not Combined antiviral and corticosteroid treatment compared with corticosteroid plus placebo or no treatment for Bell's palsy. To ensure the inclusion of all sources, the authors examined bibliographies of searched studies and contacted trial authors, experts in the field, and drug companies.
STUDY SELECTION
Randomized controlled trials or quasi-randomized controlled trials comparing antivirals alone or in combination with corticosteroids versus control therapies (corticosteroids alone, placebo, or no treatment) were included, although some of the trials were small and incompletely blinded. Trials with high risk for bias were excluded. The primary outcome was incomplete recovery of facial nerve function. Secondary outcomes included motor synkinesis, crocodile tears, and adverse events (which were not specified).
DATA EXTRACTION AND SYNTHESIS
At least 2 authors independently reviewed studies for relevance, significantly improve functional recovery compared with placebo. 5 The current review updates these findings with the inclusion of 10 randomized controlled trials. An 11th randomized controlled trial 6 was initially included in the Cochrane review published earlier 7 ; however, the trial by Abdelghany et al 6 is currently being investigated to determine the reliability of the reported data. As a result, the previous version of the 2015 Cochrane review was withdrawn and the current version was republished, excluding the trial by Abdelghany et al. 6 Unfortunately, the quality of evidence included in the current review remains mainly low to moderate.
Clinical guidelines published by the Canadian Medical Association and the American Association of
Otolaryngology-Head and Neck Surgery suggest that a combination of antivirals and corticosteroids may provide benefit in the treatment of Bell's palsy while tempering the suggestion by once again indicating that the quality of evidence remains weak to moderate. 3, 4 In the current Cochrane review, the antivirals used included acyclovir, valacyclovir, and famciclovir. A sensitivity analysis revealed a larger magnitude of effect when trials using acyclovir were excluded (risk ratio 0.65; 95% confidence interval 0.36 to 1.16), which is consistent with a recent study by Kim et al 8 that suggested famciclovir improves facial nerve recovery compared with acyclovir in patients with severe Bell's palsy. Caution should be taken when prescribing antivirals to patients with renal failure because creatinine clearance will affect the dosing regimen. Last, in practice, given the prolonged morbidity associated with Bell's palsy, it is important to provide an adequate follow-up plan and proper eye care, and inform patients that symptoms may take weeks to months to resolve. inclusion, and risk of bias. When appropriate, data were pooled with a fixed-effect model. A sensitivity analysis using a random-effect model was performed when there was significant unexplained statistical heterogeneity. The Grades of Recommendation, Assessment, Development and Evaluation working group methodology was used to assess the quality of evidence.
